Table 2.

Clinical information on LINC00261. The data for analysis were from the LUAD project in TCGA database.

Characteristic	Low Expression of LINC00261	High Expression of LINC00261	p
n	256	257
T stage, n (%)			0.223
T1	73 (14.3%)	95 (18.6%)
T2	146 (28.6%)	130 (25.5%)
T3	26 (5.1%)	21 (4.1%)
T4	9 (1.8%)	10 (2%)
N stage, n (%)			0.324
N0	162 (32.3%)	168 (33.5%)
N1	45 (9%)	50 (10%)
N2	42 (8.4%)	32 (6.4%)
N3	2 (0.4%)	0 (0%)
M stage, n (%)			0.899
M0	177 (48%)	167 (45.3%)
M1	12 (3.3%)	13 (3.5%)
Gender, n (%)			0.454
Female	133 (25.9%)	143 (27.9%)
Male	123 (24%)	114 (22.2%)
Race, n (%)			0.435
Asian	2 (0.4%)	5 (1.1%)
Black or African American	28 (6.3%)	24 (5.4%)
White	187 (41.9%)	200 (44.8%)
Age, n (%)			0.855
≤65	117 (23.7%)	121 (24.5%)
>65	129 (26.1%)	127 (25.7%)
Smoker, n (%)			0.019
No	27 (5.4%)	47 (9.4%)
Yes	221 (44.3%)	204 (40.9%)